| 中文名 | (1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
|---|---|
| 英文名 | (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester |
| 中文别名 |
雷迪帕韦中间体09
庚烷-2-羧酸叔丁酯 (1R,3S,4S)-2-(叔丁氧羰基)- 3-(6-(硼酸频哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮杂双环[2.2.1]庚烷 (1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并[D]咪唑-2-基]-2-氮杂双环-[2.2.1]-庚烷-2-羧酸叔丁酯 雷迪帕韦&索磷布韦 中间体 雷迪帕韦侧链2 (1R,3S,4S)-3-(6-(硼酸频哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 雷迪帕韦中间体1 1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮 (1R,3S,4S)-2-(叔丁氧羰基)-3-(6-(硼酸频哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮杂双环[2.2.1]庚烷 雷迪帕韦中间休 2-[(1R,3S,4S)-2-BOC-2-氮杂双环[2.2.1]庚烷-3-基]-1H-苯并咪唑-6-硼酸频哪醇酯 (1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基 来迪派韦杂质1 (1R,3S,4S)-2-(叔丁氧羰基)- 3-(6-(硼酸频哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮杂双环[2.2.1]庚烷 1256-7 3-{6-[4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)PHENYL]-1H-BENZOIMIDAZOL-2-YL}-2-AZA-BICYCLO[2.2.1]HTANE-2-CBOXYLIC ACID TERT-BUTYL ESTER百公斤 (1R,3S,4S)-3-(6-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1H-苯并[D]咪唑-2-基)基)-2-氮杂二环[2.2.1]庚烷-2-羧酸叔丁酯 |
| 英文别名 |
(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]htane-2-cboxylic acid 1,1-dimethylethyl ester
tert-butyl (1S,2S,4R)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-3-azabicyclo[2.2.1]htane-3-cboxylate 2-Methyl-2-propanyl (1R,3S,4S)-3-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylate (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-)Q: What is (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-) Q: What is the CAS Number of (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-) Q: What is the storage condition of (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-) (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1Hbenzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate (1R,3S,4S)-2-tert-butoxycarbonyl-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane 2-Azabicyclo[2.2.1]htane-2-cboxylic acid (1R,3S,4S)-2-tert-Butyl-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-benzo[d]imidazol-2-yl) 1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2 (1R,3S,4S)-2-tert-butyl-3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[D]iMidazol-2-yl)-2-azabicyclo[2.2.1]htane-2-cboxylate Identification Name (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2 (2-((1R,3S,4S)-2-(TERT-BUTOXYCBONYL)-2-AZABICYCLO[2.2.1]HTAN-3-YL)-1H-BENZO[D]IMIDAZOL-6-YL)BORONIC ACID PINACOL ESTER Ledipasvir Intermediate 1 (1R,3S,4S) (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-inden-2-yl)-2-aza-bicyclo[2.2.1]htane-2-cboxylate 2-[(1R,3S,4S)-2-Boc-2-azabicyclo[2.2.1]htan-3-yl]-1H-benzimidazole-6-boronic Acid Pinacol Ester (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]htane-2-cboxylate Identification Name (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]htane-2-cboxylic acid 1,1-dimethylethyl ester 3-{6-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]-1H-benzoimidazol-2-yl}-2-aza-bicyclo[2.2.1]htane-2-cboxylic acid tert-butyl ester (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl Intermediate of Redipavir tert-butyl (1R,3S,4S)-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]htane-2-cboxylate 2-Azabicyclo[2.2.1]htane-2-cboxylic acid, 3-[6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benziMidazol-2-yl]-, 1,1-diMethylethyl ester, (1R,3S,4S) Ledipasvir Intermediate 09 (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]htane-2-cboxylicacid1,1-dimethylethylester (1R,3S,4S)-2-tert-butyl-3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[D]iMidazol-2-yl)-2-azabicyclo[2.2.1]ht (1R,3S,4S)-3-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-ethyl ester 3-[6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-benzoimidazol-2-yl]-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester Ledipasvir Impurity 12 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 613.5±35.0 °C at 760 mmHg |
| 分子式 | C24H34BN3O4 |
| 分子量 | 439.355 |
| 闪点 | 324.8±25.9 °C |
| 精确质量 | 439.264252 |
| PSA | 76.68000 |
| LogP | 4.26050 |
| 蒸汽压 | 0.0±1.8 mmHg at 25°C |
| 折射率 | 1.583 |
| 储存条件 | 2-8°C,保存于惰性气体中 |